KUALA LUMPUR, Oct 11 -- Informa Pharma Intelligence has unveiled a new solution to optimise site selection and increase trial efficiencies to accelerate clinical trial timelines, enabling a faster path to market for drugs.
Citeline Engage is a first-to-market solution designed specifically to help optimise protocol development, site feasibility, and most importantly, increase physician engagement and drive patient awareness to support faster enrollment into clinical trials.
This solution is beneficial for contract research organisations and sponsors.
Informa Pharma Intelligence’s Citeline Engage utilises real-world data to offer the most efficient outreach services that allow customers to better recruit investigators and patients, optimise trial protocols and ignite awareness around trials.
Informa Pharma Intelligence, Vice-President (Product Development), Nicola Marlin said: “Citeline Engage empowers organisations to create and run the most efficient clinical trials possible through targeting and recruiting top tier investigators and select sites using unique online communities of verified healthcare professionals.
Informa Pharma Intelligence powers a full suite of analysis products to deliver the data needed by the pharmaceutical and biomedical industry to make decisions and create real-world opportunities for growth.
-- BERNAMA
No comments:
Post a Comment